To closely monitor the presence or progression of lung nodules – one possible sign of early-stage lung cancer – BMC offers a weekly clinic where patients can be evaluated and referred as needed for further diagnostics. Lung cancer remains the leading cause of cancer death in the U.S. and worldwide, responsible for as many deaths as the next four cancer killers (breast, prostate, colon and pancreatic) combined. Early detection of lung cancer is a very strong predictor of survival. Seventy percent of patients are diagnosed with advanced disease, stage III or IV. This has prompted efforts to find an effective mechanism to find early stage disease.
Clinical Practice Guideline: Low-Dose CT Scanning for Lung Cancer
The target population for screening with Low-Dose CT consists of smokers and former smokers aged 55 to 74 with > 30 pack years who currently
smoke or have ceased within the past 15 years.
Pre-test counseling should include a description of the potential benefits and harms of screening.
Screening should be part of a coordinated program with multiple specialists for screening and image interpretation as well as follow-up evaluation and treatment similar to participants to the National Lung Screening Trial (NLST).